Deerfield Triarc Capital - About the company
Deerfield Triarc Capital is a deadpooled company based in Springfield (United States), founded in 1994. It operates as a Provider of asset management and investment advisory services. The company has 10686 active competitors, including 277 funded and 984 that have exited. Its top competitors include companies like FIS, Fidelity Investments and S&P Global.
Key Metrics
Founded Year
1994
Location
Springfield, United States
Stage
Deadpooled
Ranked
2855th among 10686 active competitors
Similar Companies
Sign up to download Deerfield Triarc Capital's company profile
Deerfield Triarc Capital's funding and investors
Deerfield Triarc Capital has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Deerfield Triarc Capital's Competitors and alternates
Top competitors of Deerfield Triarc Capital include FIS, Fidelity Investments and S&P Global. Here is the list of Top 10 competitors of Deerfield Triarc Capital, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | FIS 1968, Jacksonville (United States), Acquired | Provider of software suite for banks and financial institutions | - | 81/100 | |
2nd | Fidelity Investments 1946, Boston (United States), Series F | Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | $4.71B | 80/100 | |
3rd | S&P Global 1917, New York City (United States), Public | Provider of essential intelligence and market analysis for global finance | - | 79/100 | |
4th | Goldman Sachs 1869, New York City (United States), Public | Provider of financial services including investment management and wealth management | - | 77/100 | |
5th | Investec 1974, London (United Kingdom), Acquired | Specialist bank and wealth manager serving private and institutional clients | - | 77/100 | |
6th | Vanguard 1976, Malvern (United States), Series B | Diversified investment management firm | $31.7M | 74/100 | |
7th | Morgan Stanley 1935, New York City (United States), Public | Provider of wealth management, investment banking, sales, trading, and research services | - | 73/100 | |
8th | Blackstone 1985, New York City (United States), Public | Diversified investment management firm | - | 71/100 | |
9th | Developer of agentic AI platform for biomedical research and drug development | $354M | 71/100 | ||
10th | JPMorgan Chase 2000, New York (United States), Public | Provider of financial services to consumers and corporations | - | 71/100 | |
2855th | Deerfield Triarc Capital 1994, Springfield (United States), Deadpooled | Provider of asset management and investment advisory services | - | - | 26/100 |
Looking for more details on Deerfield Triarc Capital's competitors? Click here to see the top ones
Deerfield Triarc Capital's Investments and acquisitions
Deerfield Triarc Capital has not made any acquisitions yet. Deerfield Triarc Capital has made 11 investments.Here is the list of latest three $investments:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Feb 19, 2016 | Investments | 2010 | Lexington (United States) | |
Dec 10, 2014 | Investments | 2013 | San Francisco (United States) | |
Jan 11, 2012 | Investments | 1984 | Nashua (United States) |
See all investments by Deerfield Triarc Capital
Reports related to Deerfield Triarc Capital
Here is the latest report on Deerfield Triarc Capital's sector:
News related to Deerfield Triarc Capital
•
Fractyl Announces Completion of $57 Million Series C Investment | FractylFractyl•Nov 19, 2015•Fractyl, Deerfield Triarc Capital, Mithril, General Catalyst and 2 others
•
Audentes Therapeutics Raises $42.5 Million In Series B FinancingAudentesTherapeutics•Dec 02, 2014•AudentesTherapeutics, Deerfield Triarc Capital, Sofinnova Investments, Venrock and 3 others
•
Audentes Therapeutics Closes $42.5M Series B Financing |FinSMEsFinSMEs•Dec 02, 2014•AudentesTherapeutics, Deerfield Triarc Capital, Sofinnova Investments, Venrock and 3 others
•
iCAD Reports Fourth Quarter and Full Year 2012 Financial Results | Business WireBusiness Wire•Feb 19, 2013•iCAD, Deerfield Triarc Capital
•
Pacific Biosciences Adds $59 MillionPE Hub•Jul 15, 2010•PacBio, Deerfield Triarc Capital, Morgan Stanley, Mohr Davidow Ventures and 7 others
•
•
Third Wave Secures $25-Million Credit FacilityBusiness Wire•Dec 10, 2007•Third Wave Technologies, Deerfield Triarc Capital
•
Novare raises $16 million for less invasive surgery instruments | VentureBeatVentureBeat•Oct 04, 2006•Novare Surgical, Tudor, Channel Medical Partners, Canaan and 3 others
•
•
Diabetes duodenal resurfacing startup Fractyl bumps Series C up to $57MFierceBiotech•Fractyl, Deerfield Triarc Capital, Mithril, General Catalyst and 2 others
Are you a Founder ?
FAQs about Deerfield Triarc Capital
Explore our recently published companies
- Illude - India based, 2019 founded, Unfunded company
- Bespokefinejewelry - Unfunded company
- Beads by Laura - United Kingdom based, Unfunded company
- Bernierobbins - Unfunded company
- Baronhats - United States based, Unfunded company
- Nivmeh - 2023 founded, Unfunded company
